leisure time -WSS

leisure time

author：comprehensive 2025-09-29 22:36:56 - browse：563

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Beam Therapeutics to lay off 20% of its staff, re

WSS

Studies point to risks of excluding people with obesity from drug trials

Senate committee scrutinizes Medicare Advantage brokers

FDA warns J&J's Abiomed: We will regulate your software

FDA warns J&J's Abiomed: We will regulate your software

Our daughter's deadly disease: trisomy 18. We wanted to protect her

AbbVie dramatically boosts its spending on lobbying

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Continuity nursing helped my family in our darkest PICU moments

How artificial intelligence is being used to detect, treat cancer

Peter Hotez and the public health issue of online harassment

Pharmacists can make shortage drugs, but at what cost?

Medical leaders decry Supreme Court decision on affirmative action

Organ transplantation is at a crossroads. Major reform is needed

Affirmative action in medical school literally saved lives

Why health workers in Gaza are injured or die at high rates

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Summit: Biotech founders on deal

knowledge

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

STAT Summit: Biotech founders on deal

Medicare reduced heart disease by changing how it pays doctors

Why an extreme heat and wildfire smoke combination can be so dangerous

Lawmakers consider Medicare pay reforms for doctors

hotspot

entertainment

hotspot

knowledge